Contract 75N92021C00025
Palogen, Inc. · Department Of Health And Human Services · September 30, 2021
Palogen, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 30, 2021 for $3.20 million of work in in-vitro diagnostic substance manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 27, 2022. If all options are exercised, the contract could reach $8.00 million.
Contract details
- PIID
- 75N92021C00025
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical- Laboratory Testing
- First action
- September 30, 2021
- Latest action
- September 27, 2022
Description
RADX TECH 2 PROJECT NUMBER 13139 PALOGEN INNOVATIVE ULTRA-FAST CHIP TECHNOLOGY FOR COVID-19 RNA DETECTION
Modification timeline
-
September 27, 2022Mod P00002 · Other Administrative Action$8.00M
-
September 30, 2021Base award$3.20M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N92021C00025?
Contract 75N92021C00025 is a federal contract awarded to Palogen, Inc. by Department Of Health And Human Services on September 30, 2021 for $3.20 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N92021C00025?
Palogen, Inc. won contract 75N92021C00025 from Department Of Health And Human Services.
How much is contract 75N92021C00025 worth?
Contract 75N92021C00025 has obligated $3.20 million to date, with a total potential value of $8.00 million if all options are exercised.